# TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT

> **NCT06622031** · NA · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 42 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Portal Vein Tumor Thrombus
- Systemic Therapy

## Interventions

- **PROCEDURE:** Transjugular intrahepatic portosystemic shunt
- **DRUG:** Lenvatinib
- **DRUG:** PD-1 inhibitor

## Key facts

- **NCT ID:** NCT06622031
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-08-30
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2025-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06622031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06622031, "TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06622031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*